Boas Gonen

HÆMOGLOBIN A1: AN INDICATOR OF THE METABOLIC CONTROL OF DIABETIC PATIENTS

Boas Gonen, H. Rochman, A. H. Rubenstein et al. · The Lancet · 1977 · 344 citations

Obesity, Metabolic Syndrome, An Indicator +13

Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy

Anders A. F. Sima, Douglas A. Greene, Morton B. Brown et al. · Journal of Diabetes and its Complications · 1993 · 68 citations · Full text

Metabolic Syndrome, Medicine, Sural Nerve Biochemistry +12

Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: Effect on nerve function

Julio V. Santiago, Peter H. Sönksen, Andrew J.M. Boulton et al. · Journal of Diabetes and its Complications · 1993 · 64 citations

Diabetes Management, Nerve Function, Medicine +6

Familial nesidioblastosis: Severe neonatal hypoglycemia in two families

Stanley S. Schwartz, Barry H. Rich, Anne W. Lucky et al. · The Journal of Pediatrics · 1979 · 58 citations

Severe Neonatal Hypoglycemia, Neonatology, Pathogenesis +4

Metabolic Control in Diabetic Patients: Effect of Insulin-secretory Reserve (Measured by Plasma C-Peptide Levels) and Circulating Insulin Antibodies

Boas Gonen, José Goldman, David Baldwin et al. · Diabetes · 1979 · 56 citations

Circulating Insulin Antibodies, Immunology, Insulin Signaling +17